The same caloric reduction that produces healthy weight loss in a middle-aged adult can accelerate muscle loss in a senior, a condition called sarcopenia that already worsens naturally with age
semaglutide: Blood sugar management Semaglutide has direct, measurable effects on blood sugar regulation and is used as a diabetes medication
Those can include nausea, bone density loss, and digestive troublesand according to a new study, another physical change may be joining that list
A technically impressive peptide does very little if the product is unstable, unpleasant to use, or too expensive to apply twice daily over a broad area
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes or hypertension
1 The MHRA has confirmed this, with the UK indication covering adults with a BMI of 30 or above, or adults with a BMI of 27 or above with at least one weight-related health condition